These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7566968

  • 1. Somatic mutations in the VI transmembrane segment of the thyrotropin receptor constitutively activate cAMP signalling in thyroid hyperfunctioning adenomas.
    Porcellini A, Ciullo I, Pannain S, Fenzi G, Avvedimento E.
    Oncogene; 1995 Sep 21; 11(6):1089-93. PubMed ID: 7566968
    [Abstract] [Full Text] [Related]

  • 2. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.
    Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G.
    Nature; 1993 Oct 14; 365(6447):649-51. PubMed ID: 8413627
    [Abstract] [Full Text] [Related]

  • 3. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades.
    Parma J, Van Sande J, Swillens S, Tonacchera M, Dumont J, Vassart G.
    Mol Endocrinol; 1995 Jun 14; 9(6):725-33. PubMed ID: 8592518
    [Abstract] [Full Text] [Related]

  • 4. Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells.
    Porcellini A, Ruggiano G, Pannain S, Ciullo I, Amabile G, Fenzi G, Avvedimento EV.
    Oncogene; 1997 Aug 14; 15(7):781-9. PubMed ID: 9266964
    [Abstract] [Full Text] [Related]

  • 5. Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid.
    Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G.
    J Clin Endocrinol Metab; 1994 Dec 14; 79(6):1785-9. PubMed ID: 7989485
    [Abstract] [Full Text] [Related]

  • 6. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism.
    Duprez L, Parma J, Van Sande J, Allgeier A, Leclère J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J.
    Nat Genet; 1994 Jul 14; 7(3):396-401. PubMed ID: 7920658
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Constitutively activating mutations of the thyrotropin receptor and thyroid disease.
    Führer D, Holzapfel HP, Wonerow P, Paschke R.
    Eur J Med Res; 1996 Jul 25; 1(10):460-4. PubMed ID: 9438142
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
    Castro I, Lima L, Seoane R, Lado-Abeal J.
    Thyroid; 2009 Jun 25; 19(6):645-9. PubMed ID: 19499991
    [Abstract] [Full Text] [Related]

  • 12. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas.
    Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P, Van Vliet G, Costagliola S, Rodien P, Dumont JE, Vassart G.
    J Clin Endocrinol Metab; 1997 Aug 25; 82(8):2695-701. PubMed ID: 9253356
    [Abstract] [Full Text] [Related]

  • 13. Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil.
    Nogueira CR, Kopp P, Arseven OK, Santos CL, Jameson JL, Medeiros-Neto G.
    Thyroid; 1999 Nov 25; 9(11):1063-8. PubMed ID: 10595453
    [Abstract] [Full Text] [Related]

  • 14. Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy.
    Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G, Avvedimento VE.
    J Clin Endocrinol Metab; 1994 Aug 25; 79(2):657-61. PubMed ID: 8045989
    [Abstract] [Full Text] [Related]

  • 15. TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5.
    Karges B, Krause G, Homoki J, Debatin KM, de Roux N, Karges W.
    J Endocrinol; 2005 Aug 25; 186(2):377-85. PubMed ID: 16079263
    [Abstract] [Full Text] [Related]

  • 16. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor].
    Kosugi S.
    Nihon Rinsho; 2002 Feb 25; 60(2):291-6. PubMed ID: 11857916
    [Abstract] [Full Text] [Related]

  • 17. Activating mutations of the TSH receptor in differentiated thyroid carcinomas.
    Russo D, Arturi F, Schlumberger M, Caillou B, Monier R, Filetti S, Suárez HG.
    Oncogene; 1995 Nov 02; 11(9):1907-11. PubMed ID: 7478621
    [Abstract] [Full Text] [Related]

  • 18. Mutations of thyrotropin receptor gene.
    Porcellini A, Fenzi G, Avvedimento EV.
    J Mol Med (Berl); 1997 Aug 02; 75(8):567-75. PubMed ID: 9297624
    [Abstract] [Full Text] [Related]

  • 19. Thyrotropin receptor: a role for thyroid tumourigenesis?
    Russo D, Arturi F, Chiefari E, Filetti S.
    Forum (Genova); 1999 Aug 02; 9(2):166-75. PubMed ID: 10385711
    [Abstract] [Full Text] [Related]

  • 20. Thyroid hyperfunctioning adenomas with and without Gsp/TSH receptor mutations show similar clinical features.
    Arturi F, Capula C, Chiefari E, Filetti S, Russo D.
    Exp Clin Endocrinol Diabetes; 1998 Aug 02; 106(3):234-6. PubMed ID: 9710366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.